Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC)

De Hert, M., Dekker, J.M., Wood, D., Kahl, K.G., Holt, R.I.G., Möller, H.-J.·2009·European Psychiatry

DOI 10.1016/j.eurpsy.2009.01.005

Cited by (948)

Items 301–400 of 948

A four-year naturalistic prospective study of cardiometabolic disease in antipsychotic-treated patients
Paul Mackin, Tony Waton, Helen Watkinson, Peter Gallagher · 2010 · European Psychiatry
Contemporary approaches in mental health rehabilitation
Lisette van der Meer, Charlotte Wunderink · 2018 · Epidemiology and Psychiatric Sciences
Psychische Erkrankungen und Diabetes mellitus (Update 2019)
Heidemarie Abrahamian, Alexandra Kautzky‐Willer, Angelika Rießland-Seifert, Peter Fasching, Christoph F. Ebenbichler, Alexander Kautzky, Peter Hofmann, Hermann Toplak · 2019 · Wiener klinische Wochenschrift
Diabetes, cardiovascular disease, and health care use in people with and without schizophrenia
Lauren C. Bresee, Sumit R. Majumdar, Scott Burton Patten, Jeffrey A. Johnson · 2010 · European Psychiatry
Comparative cost-effectiveness of 11 oral antipsychotics for relapse prevention in schizophrenia within Singapore using effectiveness estimates from a network meta-analysis
Liang Lin, Ying Jiao Zhao, Hui Zhou, Ai Leng Khoo, Monica Teng, Lay Beng Soh, Boon Peng Lim, Kang Sim · 2015 · International Clinical Psychopharmacology
The prevalence of cardiometabolic risk factors and the ten-year risk of fatal cardiovascular events in patients with schizophrenia and related psychotic disorders.
Dita Protopopová, Jiří Masopust, Radován Malý, Martin Vališ, Jan Bažant · 2012 · PubMed
Microvascular dysfunction in schizophrenia: a case–control study
Martin Vetter, Billie‐Jean Martin, Marinda Fung, Milada Pajevic, Todd J. Anderson, Thomas J. Raedler · 2015 · Schizophrenia
Atypical antipsychotics: recent research findings and applications to clinical practice: Proceedings of a symposium presented at the 29th Annual European College of Neuropsychopharmacology Congress, 19 September 2016, Vienna, Austria
Robin M. Murray, Christoph Ulrich Correll, Gavin P. Reynolds, David M. Taylor · 2017 · Therapeutic Advances in Psychopharmacology
Individualizing antipsychotic treatment selection in schizophrenia: characteristics of empirically derived patient subgroups
Christoph Ulrich Correll, F. Cañas, Ilkka Larmo, P. Levy, J.M. Montes, Andrea M. Fagiolini, Georgios Papageorgiou, Alessandro Rossi, Runa Sturlason, Mathias Zink · 2011 · European Psychiatry
Changes in metabolic parameters in patients with severe mental illness over a 10-year period: A retrospective cohort study
A. Heald, J. L. Martin, T. Payton, Luma Khalid, S. Anderson, R. Narayanan, M. de Hert, A. Yung, M. Livingston · 2017 · Australian and New Zealand journal of psychiatry (Print)
Diabetes mellitus risk for 102 drugs and drug combinations used in patients with bipolar disorder
Anastasiya Nestsiarovich, Berit Kerner, Aurélien Mazurie, Daniel C. Cannon, Nathaniel G. Hurwitz, Yiliang Zhu, Stuart J. Nelson, Tudor Ionel Oprea, Annette S. Crisanti, Mauricio F. Tohen et al. · 2019 · Psychoneuroendocrinology
Cumulative dosages of antipsychotic drugs are associated with increased mortality rate in patients with Alzheimer's dementia
René Ernst Nielsen, Annette Lolk, Jan Brink Valentin, Kjeld Andersen · 2016 · Acta Psychiatrica Scandinavica
Implementation of recommended type 2 diabetes care for people with severe mental illness – a qualitative exploration with healthcare professionals
Hayley B. McBain, Kathleen Mulligan, Frédérique Lamontagne-Godwin, Julia Jones, Mark Haddad, Chris Flood, David A. Thomas, Alan Simpson · 2016 · BMC Psychiatry
Change in psychiatrists’ attitudes towards the physical health care of patients with schizophrenia coinciding with the dissemination of the consensus on physical health in patients with schizophrenia
Julio Bobes, Analucía A. Alegría, María Dolores Sáiz-González, I. Barber, J.L. Pérez, J. Sáiz‐Ruiz · 2010 · European Psychiatry
Alterations of cellular aging markers in obsessive–compulsive disorder: mitochondrial DNA copy number and telomere length
Jee In Kang, Chun Il Park, Jue Lin, Shin Tae Kim, Hae Won Kim, Se Joo Kim · 2021 · Journal of Psychiatry and Neuroscience
Design and rationale of a randomized controlled trial to reduce cardiovascular disease risk for patients with bipolar disorder
David E. Goodrich, Amy M. Kilbourne, Zongshan Lai, Edward P. Post, Nicholas W. Bowersox, Briana R. Mezuk, Karen L. Schumacher, Margretta Bramlet, Deborah E. Welsh, Mark S. Bauer · 2012 · Contemporary Clinical Trials
Effects of risperidone treatment on the expression of hypothalamic neuropeptide in appetite regulation in Wistar rats
Canan Kurşungöz, Mehmet Ak, Tülin Yanık · 2014 · Brain Research
Screening of cardiovascular risk factors in patients with schizophrenia and patients treated with antipsychotic drugs: are we equally exhaustive as with the general population?
Miguel Castillo Sánchez, Mireia Fàbregas Escurriola, Daniel Bergé, MªIsabel Fernández-SanMartín, Albert Goday · 2017 · Clinical and Experimental Hypertension
Better Health Choices: Feasability and preliminary effectiveness of a peer delivered healthy lifestyle intervention in a community mental health setting
Peter J. Kelly, Amanda Baker, Naomi L. Fagan, Alyna Turner, Frank Patrick Deane, Rebecca McKetin, Robin Callister, Clare Elizabeth Collins, Isabella Ingram, Keren Wolstencroft et al. · 2019 · Addictive Behaviors
An Evidence-Based Review of OLZ/SAM for Treatment of Adults with Schizophrenia or Bipolar I Disorder
Leslie Citrome, Christine E. Graham, Adam Simmons, Ying Jiang, Mark S. Todtenkopf, Bernard L. Silverman, Lauren DiPetrillo, Hannah Cummings, Lei Sun, David McDonnell · 2021 · Neuropsychiatric Disease and Treatment
Cardiovascular disease and excess mortality in depression: physical activity as a game changer
Markus Gerber, MC Claussen, R Cody, Christian Imboden, Sebastian Ludyga, Johannes Scherr, Erich Seifritz, Roland von Känel · 2021 · German Journal of Sports Medicine
Type 2 diabetes and pre-diabetic abnormalities in patients with bipolar disorders
Karolina Leopold, Andreas Reif, Sarah Haack, Michael Bauer, Daniel Bury, Antje Löffler, Sarah Kittel‐Schneider, Steffi Pfeiffer, Cathrin Sauer, Peter E. H. Schwarz et al. · 2015 · Journal of Affective Disorders
Predictors of rapid high weight gain in schizophrenia: Longitudinal analysis of the French FACE-SZ cohort
Ophélia Godin, Marion Leboyer, Franck Schürhoff, Laurent Boyer, Meja Andrianarisoa, Lore Brunel, Ewa Bulzacka, Bruno Aouizerate, Fabrice Sébastien Berna, Delphine Capdevielle et al. · 2017 · Journal of Psychiatric Research
Protocol for CHANGE: a randomized clinical trial assessing lifestyle coaching plus care coordination versus care coordination alone versus treatment as usual to reduce risks of cardiovascular disease in adults with schizophrenia and abdominal obesity
Speyer, Helene, Nørgaard, Hans Christian Brix, Hjorthøj, Carsten, Madsen, Thomas Axel, Drivsholm, Søren, Pisinger, Charlotta, Gluud, Christian, Mors, Ole, Krogh, Jesper, Nordentoft, Merete · 2015 · BMC Psychiatry
Evaluating Monitoring Guidelines of Clozapine-Induced Adverse Effects: a Systematic Review
Sarah Smessaert, Johan Detraux, Siska Desplenter, Marc D. Binder · 2024 · CNS Drugs
Obesity in Adults: Position Statement of Polish Association for the Study on Obesity, Polish Association of Endocrinology, Polish Association of Cardiodiabetology, Polish Psychiatric Association, Section of Metabolic and Bariatric Surgery of the Association of Polish Surgeons, and the College of Family Physicians in Poland
Magdalena Olszanecka‐Glinianowicz, Artur Mazur, Jerzy Tadeusz Chudek, Beata Kos‐Kudła, Leszek Markuszewski, Dominika Dudek, Piotr Major, Piotr Małczak, Wiesław Tarnowski, Paweł Jaworski et al. · 2023 · Nutrients
Knowledge of Psychiatric Nurses About the Potentially Lethal Side-Effects of Clozapine
Marc D. Binder, Annelien De Beugher, Kim Sweers, Martien Wampers, Christoph Ulrich Correll, Dan Cohen · 2015 · Archives of Psychiatric Nursing
The prevalence of metabolic syndrome and its associated factors in long-term patients in a specialist psychiatric hospital in South Africa
K Maaroganye, M Mohapi, Christa Krüger, Paul Rheeder · 2013 · African Journal of Psychiatry
Management of type 2 diabetes mellitus in people with severe mental illness: an online cross-sectional survey of healthcare professionals
Hayley B. McBain, Frédérique Lamontagne-Godwin, Mark Haddad, Alan Simpson, Jacqui Chapman, Julia Jones, Chris Flood, Kathleen Mulligan · 2018 · BMJ Open
Chapter 12 – Type 2 Diabetes Mellitus
D. Vancampfort, Richard I. G. Holt, B. Stubbs, M. de Hert, K. Samaras, A. Mitchell · 2016 · Elsevier eBooks
Cardiovascular Screening of People With Severe Mental Illness in England: Views of Service Users and Providers
Alexandra Pitman, David Osborn, Christine Wright, Irwin Nazareth, Michael King · 2011 · Psychiatric Services
Screening, Diagnosis, and Treatment of Dyslipidemia Among Persons With Persistent Mental Illness: A Literature Review
Erik R. Vanderlip, Jess G. Fiedorowicz, William Geoffrey Haynes · 2012 · Psychiatric Services
Alexithymia, more than depression, influences glycaemic control of type 2 diabetic patients
Antonina Luca, Maria Luca, M. Di Mauro, Filippo Palermo, Francesco Rampulla, Carmela Calandra · 2015 · Journal of Endocrinological Investigation
Antipsychotic‐associated all‐cause and cardiac mortality: what should we worry about and how should the risk be assessed?
Christoph Ulrich Correll, Jimmi Nielsen · 2010 · Acta Psychiatrica Scandinavica
Addressing the disparity in physical health provision for people with schizophrenia: an important role for physiotherapists
Brendon Stubbs, Andrew Soundy, Michel Probst, A Parker, Liv Helvik Skjærven, Amanda Lundvik Gyllensten, Davy Vancampfort · 2013 · Physiotherapy
Dealing With Existential Suffering of Patients With Severe Persistent Mental Illness: Experiences of Psychiatric Nurses in Flanders (Belgium)
Christoph Moonen, Joke Lemiengre, Chris Gastmans · 2015 · Archives of Psychiatric Nursing
Meeting the needs? Perceived support of a nurse‐led lifestyle programme for young adults with mental illness in a primary health‐care setting
Ylva Rönngren, Annette Björk, Lisbeth Porskrog Kristiansen, David Haage, Ingela Enmarker, Åsa Audulv · 2017 · International Journal of Mental Health Nursing
T4 and waist:hip ratio as biomarkers of antipsychotic-induced weight gain in Han Chinese inpatients with schizophrenia
Shen Li, Ying Gao, Hao Lv, Miaomiao Zhang, Lili Wang, Rui Jiang, Chengai Xu, Xueshi Wang, Ming Gao, Yukun He et al. · 2017 · Psychoneuroendocrinology
Interventions to integrate care for people with serious mental illness and substance use disorders: a systematic scoping review protocol
Amy Richardson, Lauralie Richard, Kathryn E. Gunter, Sarah Derrett · 2019 · BMJ Open
Guidelines for the management of type 2 diabetes: is ADA and EASD consensus more clinically relevant than the IDF recommendations?
Leszek Czupryniak · 2009 · Diabetes Research and Clinical Practice
The metabolic syndrome in an Italian psychiatric sample: a retrospective chart review of inpatients treated with antipsychotics
Ilaria Santini, Paolo Stratta, Simona D’Onofrio, Ida De Lauretis, Valeria Santarelli, Francesca Pacitti, Alessandro Rossi · 2016 · Rivista di psichiatria
Glucose, cholesterol and blood pressure in type II diabetes: A longitudinal observational study comparing patients with and without severe mental illness
Robert David Smith, Lu Han, Shehzad Ali, Stephanie Louise Prady, Joanne Taylor, Tom Hughes, Ramzi Ajjan, Najma Siddiqi, Tim Doran · 2019 · Journal of Psychiatric and Mental Health Nursing
No evidence for metabolic syndrome and lipid profile differences in patients suffering from bipolar I disorder with and without suicide attempts
Mohammad Ahmadpanah, Mohammad Haghighi, Leila Jahangard, Shiva Borzooei, Safora Heshmati, Hafez Bajoghli, Edith Holsboer‐Trachsler, Serge Brand · 2015 · International Journal of Psychiatry in Clinical Practice
Let's get physical: improving the medical care of people with severe mental illness
Alex J. Mitchell, Vijay Delaffon, Oliver Lord · 2012 · Advances in Psychiatric Treatment
Using motivational techniques to reduce cardiometabolic risk factors in long term psychiatric inpatients: a naturalistic interventional study
Ringen, Petter Andreas, Falk, Ragnhild S., Antonsen, Bjørnar, Faerden, Ann, Mamen, Asgeir, Rognli, Eline B., Solberg, Dag K., Martinsen, Egil W., Andreassen, Ole A. · 2018 · BMC Psychiatry
A cross sectional study of psychotropic medicine use in Australia in 2018: a focus on polypharmacy
Brett, Jonathan, Pearson, Sallie‐Anne, Daniels, Benjamin, Wylie, Claire E., Buckley, Nicholas A. · 2021 · British Journal of Clinical Pharmacology
Cardiometabolic comorbidity in antipsychotic treated patients: need for systematic evaluation and treatment
P. Steylen, Frank M. M. A. Van der Heijden, H. Kok, N. Sijben, Willem M. A. Verhoeven · 2013 · International Journal of Psychiatry in Clinical Practice
Move your mind: embedding accredited exercise physiology services within a hospital-based mental health service
Bonnie J Furzer, Kemi E. Wright, Azam Edoo, Andrew Maiorana · 2020 · Australasian Psychiatry
Effects and Feasibility of the “Traffic Light Method for Somatic Screening and Lifestyle” in Patients With Severe Mental Illness: A Pilot Study
Berno van Meijel, Sonja van Hamersveld, Ronald van Gool, Jaap van der Bijl, Peter N. van Harten · 2014 · Perspectives In Psychiatric Care
Homocysteine and other markers of cardiovascular risk during a manic episode in patients with bipolar disorder
Fábria Chiarani, Juliana Tramontina, Keila Maria Mendes Ceresér, Maurício Kunz, Leonardo Ludwig Paim, Carmen Regla Vargas, Ângela Sitta, Sérgio Pinto Machado, Ângela Terezinha de Souza Wyse, Flávio Pereira Kapczinski · 2013 · Brazilian Journal of Psychiatry
Measurement of Metabolic Monitoring in Youth and Adult Medicaid Recipients Prescribed Antipsychotics
Gail Ann Edelsohn, Meghna Parthasarathy, Lauren A. Terhorst, Irina O. Karpov, James Schuster · 2015 · Journal of Managed Care & Specialty Pharmacy
Do routine outcome monitoring results translate to clinical practice? A cross-sectional study in patients with a psychotic disorder
Magda Tasma, Marte Swart, Gert Wolters, Edith Jantine Liemburg, Richard Bruggeman, Henderikus Knegtering, Stynke Castelein · 2016 · BMC Psychiatry
Olanzapine and aripiprazole differentially affect glucose uptake and energy metabolism in human mononuclear blood cells
Britta Stapel, Alexandra Kotsiari, Michaela Scherr, Denise Hilfiker‐Kleiner, Stefan Bleich, Helge Frieling, Kai G. Kahl · 2016 · Journal of Psychiatric Research
Encounter of Pepper-CPGE for the elderly and patients with schizophrenia: an innovative strategy to improve patient's recreation, rehabilitation, and communication
Ujike Shoko, Yuko Yasuhara, Kyoko Osaka, Miki Sato, Elmer Javier Catangui, Shoko Edo, Eiji Takigawa, Yoshihiro Mifune, Tetsuya Tanioka, Kazushi Mifune · 2019 · The Journal of Medical Investigation
Physical health in affective disorders: a narrative review of the literature
Lluc Colomer, Gerard Anmella, Eduard Vieta, Iría Grande · 2020 · Brazilian Journal of Psychiatry
Cardiovascular Health Issues in Inner City Populations
Dhruv Nayyar, Stephen W. Hwang · 2015 · Canadian Journal of Cardiology
Psychische Erkrankungen und Diabetes mellitus
Heidemarie Abrahamian, Alexandra Kautzky‐Willer, Angelika Rießland-Seifert, Peter Fasching, Christoph F. Ebenbichler, Peter Hofmann, Hermann Toplak · 2016 · Wiener klinische Wochenschrift
Co-prescription of medication for bipolar disorder and diabetes mellitus: a nationwide population-based study with focus on gender differences
Svendal, Gjertrud, Fasmer, Ole Bernt, Engeland, Anders, Berk, Michael, Lund, Anders · 2012 · BMC Medicine
Acute hospital service utilization by inpatients in psychiatric hospitals
John Lally, Yim Lun Wong, Hitesh Shetty, Anita K. Patel, Vivek Srivastava, Matthew T.M. Broadbent, Fiona Gaughran · 2015 · General Hospital Psychiatry
Incidence of cardiovascular diseases and type-2-diabetes mellitus in patients with psychiatric disorders
Nawal Bent‐Ennakhil, Marie‐Cécile Perier, Patrik Sobocki, Dan Gothefors, Gunnar S Johansson, Dominique Milea, Jean Philippe Empana · 2018 · Nordic Journal of Psychiatry
Diabetes pay-for-performance program can reduce all-cause mortality in patients with newly diagnosed type 2 diabetes mellitus
Fang-Ping Kung, Ching-Fang Tsai, Chin‐Li Lu, Li-Chung Huang, Chieh‐Hsiang Lu · 2020 · Medicine
Prevalence and correlates of metabolic syndrome and its components in adults with psychotic disorders in Eldoret, Kenya
Edith Kamaru Kwobah, Nastassja Koen, Ann Mwangi, Lukoye Atwoli, Dan Joseph Stein · 2021 · PLoS ONE
Improvements in metabolic abnormalities among overweight schizophrenia and bipolar disorder patients
Antonio Ventriglio, Alessandro Gentile, Ross J. Baldessarini, Sara Martone, Giovanna Vitrani, Antonio La Marca, Antonello Bellomo · 2014 · European Psychiatry
Antihypertensive treatment and control according to gender, education, country of birth and psychiatric disorder: the Swedish Primary Care Cardiovascular Database (SPCCD)
Charlotta E. A. Ljungman, Thomas Kahan, Linus Schiöler, Per Hjerpe, Björn Wettermark, Kristina Bengtsson Boström, Karin Manhem · 2014 · Journal of Human Hypertension
The concomitant use of second-generation antipsychotics and long-term antiretroviral therapy may be associated with increased cardiovascular risk
Maria Ferrara, Anya Umlauf, Chelsea Sanders, Jonathan M. Meyer, John Allen McCutchan, Nichole A. Duarte, Joseph Hampton Atkinson, Igor Grant, Ronald J. Ellis · 2014 · Psychiatry Research
Severe mental disorders and vaccinations – a systematic review
Nina Bonkat, Frederike T. Fellendorf, Nina Dalkner, Eva Z. Reininghaus · 2022 · The World Journal of Biological Psychiatry
Adult-onset type 1 diabetes: A changing perspective
J Burahmah, Deqing Zheng, Richard David Leslie · 2022 · European Journal of Internal Medicine
Relevance of diet in schizophrenia: a review focusing on prenatal nutritional deficiency, obesity, oxidative stress and inflammation
Viorica Rarinca, Amalia Vasile, Mălina Visternicu, Vasile Burlui, Gabriela Halitchi, Alin Stelian Ciobica, Ana-Maria Sîngeap, Romeo Dobrin, Ecaterina Burlui, Lucian Maftei et al. · 2024 · Frontiers in Nutrition
A prospective study of glucose homeostasis in quetiapine-treated schizophrenic patients by using the intravenous glucose tolerance test
Chun-Hsin Chen, Tsang‐Yaw Lin, Tzu-Ting Chen, Vincent Chin‐Hung Chen, Ni-Chi Lin, Wen‐Chuan Shao, Mong‐Liang Lu · 2011 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
Second-Generation Antipsychotics in Adolescent Psychiatric Patients: Metabolic Effects and Impact of an Early Weight Change to Predict Longer Term Weight Gain
Frederik Vandenberghe, Alexandra Najar-Giroud, Laurent Holzer, Philippe Conus, Chin B. Eap, Anne‐Emmanuelle Ambresin · 2018 · Journal of Child and Adolescent Psychopharmacology
Physical health in individuals with psychiatric disorders in Austria.
B. Reininghaus, K. Riedrich, N. Dalkner, L. A. Lehner, A. Rieger, C. Hamm, M. Dorn, Leopold Gradauer, Alois Hufnagl, Markus Mayr-Mauhart et al. · 2019 · Journal of Affective Disorders
Cigarette Smoking and Interest in Quitting Among Overweight and Obese Adults With Serious Mental Illness Enrolled in a Fitness Intervention
Kelly A. Aschbrenner, Mary F. Brunette, Raleigh McElvery, John A. Naslund, Emily A. Scherer, Sarah I. Pratt, Stephen J. Bartels · 2015 · The Journal of Nervous and Mental Disease
Health promotion intervention in mental health care: design and baseline findings of a cluster preference randomized controlled trial
Nick Verhaeghe, Jan De Maeseneer, Lea Maes, Cornelis Van Heeringen, Veerle Bogaert, Els Clays, Dirk De Bacquer, Lieven Annemans · 2012 · BMC Public Health
Utilization of General and Specialized Cardiac Care by People With Schizophrenia
Lauren C. Bresee, Sumit R. Majumdar, Scott Burton Patten, Jeffrey A. Johnson · 2012 · Psychiatric Services
Nonpsychiatric Outpatient Care for Adults With Serious Mental Illness in California: Who Is Being Left Behind?
Maria E. Garcia, Dean Schillinger, Eric Vittinghoff, Jennifer M. Creasman, Penelope Knapp, John W. Newcomer, Christina V. Mangurian · 2017 · Psychiatric Services
Increased pericardial adipose tissue and cardiometabolic risk in patients with schizophrenia versus healthy controls
J. Ruppert, D Hartung, Mechthild Westhoff‐Bleck, J. Herrmann, Brendon Stubbs, J. Cordes, Tillmann H. C. Krüger, Ralf Lichtinghagen, Kai G. Kahl · 2017 · European Archives of Psychiatry and Clinical Neuroscience
Strategies for successful clinical management of schizophrenia with ziprasidone
Andrea M. Fagiolini, Fernando Cañas, B. Gallhofer, Ilkka Larmo, Pedro Levy, José Manuel García Montes, Georgios Papageorgiou, Mathias Zink, Alessandro Rossi · 2010 · Expert Opinion on Pharmacotherapy
Development of a Supported Self-management Intervention for People With Severe Mental Illness and Type 2 Diabetes: Theory and Evidence-Based Co-design Approach
Claire Carswell, Peter A Coventry, Jennifer Valeska Elli Brown, Sarah Louise Alderson, Keith Double, Simon M. Gilbody, Richard I. G. Holt, Rowena Jacobs, Jennie Lister, David Osborn et al. · 2023 · Journal of Medical Internet Research
Assessment of cardiovascular disease risk in patients with schizophrenia spectrum disorders in German psychiatric hospitals: results of the pharmacoepidemiologic CATS study
Michael Deuschle, Friedemann Paul, M. Brosz, N. Bergemann, M. Franz, Jutta Kammerer-Ciernioch, M. Lautenschlager, Florian Lederbogen, Daniela Roesch-Ely, Matthias Weisbrod et al. · 2013 · Social Psychiatry and Psychiatric Epidemiology
Type 2 Diabetes in Children and Adolescents on Atypical Antipsychotics
Pornpoj Pramyothin, Lalita Khaodhiar · 2015 · Current Diabetes Reports
Poor monitoring of physical health in patients referred to a mood disorders service
David Lack, Richard I. G. Holt, David S. Baldwin · 2014 · Therapeutic Advances in Psychopharmacology
Pharmacological treatment of schizophrenia
Ary Gadelha, Cristiano de Souza Noto, Jair de Jesus Mari · 2012 · International Review of Psychiatry
Health care disparities among persons with comorbid schizophrenia and cardiovascular disease: a case–control epidemiological study
Gilad Gal, Hanan Munitz, I. Levav · 2015 · Epidemiology and Psychiatric Sciences
Psychiatric Disorders - Worldwide Advances
T. Uehara · 2011 · InTech eBooks
Cardiovascular disease lifestyle risk factors in people with psychosis: a cross-sectional study
Doreen Mucheru, Mary‐Claire Hanlon, Linda Campbell, Mark McEvoy, Lesley K. MacDonald‐Wicks · 2018 · BMC Public Health
Strategies to deal with comorbid physical illness in psychosis
Mary Jane Docherty, Brendon Stubbs, Fiona Gaughran · 2016 · Epidemiology and Psychiatric Sciences
Biographical disruption, redefinition, and recovery: Illness identities of women with depression and diabetes
Deborah Anne Potter · 2023 · Health An Interdisciplinary Journal for the Social Study of Health Illness and Medicine
Observation of the extent of smoking in a mental health inpatient facility with a smoke-free policy
Paula M. Wye, Leanne Gow, Jude Constable, Jenny Bowman, Sharon Lawn, John Henry Wiggers · 2014 · BMC Psychiatry
Impacto del Consenso Español sobre la Salud Física del Paciente con Esquizofrenia
Jerónimo Sáiz-Ruiz, María Dolores Sáiz-González, Analucía A. Alegría, Esperanza Mata Mena, Julia Luque, Julio Bobes · 2010 · Revista de Psiquiatría y Salud Mental
Discovery of natural product inhibitors of phosphodiesterase 10A as novel therapeutic drug for schizophrenia using a multistep virtual screening
Mayasah Y. Al-Nema, Anand Gaurav, Gabriel Akyirem Akowuah · 2018 · Computational Biology and Chemistry
The Physical Health Care Fidelity Scale: Psychometric Properties
Torleif Ruud, Tordis Sørensen Høifødt, Delia Cimpean Hendrick, Robert E. Drake, Anne Høye, Matthew Landers, Kristin Sverdvik Heiervang, Gary R. Bond · 2020 · Administration and Policy in Mental Health and Mental Health Services Research
Cardiovascular risk screening of patients with serious mental illness or use of antipsychotics in family practice
Kirsti M. Jakobs, Anne Posthuma, Wim J. C. de Grauw, Bianca W. M. Schalk, Reinier P. Akkermans, Peter LBJ Lucassen, Tjard R. Schermer, Willem JJ Assendelft, Marion C. J. Biermans · 2020 · BMC Family Practice
The Acceptability and Feasibility of Using Text Messaging to Support the Delivery of Physical Health Care in those Suffering from a Psychotic Disorder: a Review of the Literature
Henry Griffiths · 2020 · Psychiatric Quarterly
Undoing Descartes: integrating diabetes care for those with mental illness
RIG Holt · 2011 · Practical Diabetes
Diabetes treatment in people with type 2 diabetes and schizophrenia: Retrospective primary care database analyses
Wolfgang Rathmann, Stefan Pscherer, Marcel Konrad, Karel Kostev · 2015 · Primary care diabetes
Integrating an internet-mediated walking program into family medicine clinical practice: a pilot feasibility study
David E. Goodrich, Lorraine R Buis, Adrienne W Janney, Megan D Ditty, Christine W Krause, Kai Zheng, Ananda Sen, Victor J. Strecher, Michael L Hess, John D. Piette et al. · 2011 · BMC Medical Informatics and Decision Making
Depot risperidone-induced adverse metabolic alterations in female rats
Kateřina Horská, Jana Kučerová, Michal Karpíšek, Pavel Suchý, Radka Opatřilová, Hana Kotolová · 2017 · Journal of Psychopharmacology
Autonomic nervous activity of patient with schizophrenia during Pepper CPGE-led upper limb range of motion exercises
Ryuichi Tanioka, Yuko Yasuhara, Kyoko Osaka, Yoshihiro KAI, Yueren Zhao, Tetsuya Tanioka, Kensaku Takase, Michael Joseph S. Diño, Rozzano C. Locsin · 2020 · Enfermería Clínica
Prevalence and Associated Factors of Metabolic Syndrome Among Patients with Severe Mental Illness at Hawassa, Southern-Ethiopia
Tesfaye Teshome, Dejene Hailu Kassa, Agete Tadewos Hirigo · 2020 · Diabetes Metabolic Syndrome and Obesity
Is the use of an invitation letter effective in prompting patients with severe mental illness to attend a primary care physical health check?
Sheila Hardy, Richard John Gray · 2012 · Primary Health Care Research & Development